OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval.

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...

Purdue Pharma won bankruptcy court approval for an opioid-related settlement of at least $7.4 billion, clearing a path for ...

The new agreement replaces one the US Supreme Court rejected last year, finding it would have improperly protected members of ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...

In our news wrap Friday, a federal bankruptcy judge will approve Purdue Pharma’s latest deal to settle lawsuits over the ...

Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...

A judge said he will approve a $7 billion settlement between the maker of OxyContin and people with addiction, states, ...

OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...

While AI has accelerated drug discovery, the same technology can address clinical trial bottlenecks that have persisted for ...